Stefan Eschbach Overview
- Investor Type
-
Angel
- Investments
-
1
- Exits
-
1
Stefan Eschbach General Information
Description
Dr. Stefan Eschbach serves as an Advisor at Antrad Medical. He served as Chairman & President at BioReperia. He is also an Angel Investor. Mr. Stefan Eschbach served as Chairman at Glycobond. He has 25 years of experience in the international life science industry. Former Executive Vice President and General Manager at Phadia. More than 10 years responsible for a business unit including R&D, production and sales. Prior to that held leading positions in Germany and abroad.
Business Details
Primary Investor Type
Stefan Eschbach Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Glycobond | 08-Apr-2015 | Discovery Tools (Healthcare) | Bankruptcy: Liquidation |
Stefan Eschbach Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Glycobond | 02-Sep-2024 |
Stefan Eschbach Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Stefan Eschbach FAQs
-
Who is Stefan Eschbach?
Stefan Eschbach is an angel Investor who has made 1 investment.
-
What kind of investor is Stefan Eschbach?
Stefan Eschbach is an angel investor.
-
What does Stefan Eschbach do?
As an angel investor, Stefan Eschbach invests personal money into promising companies, typically in exchange for equity.
-
What has Stefan Eschbach invested in?
Stefan Eschbach has invested in Glycobond within the Discovery Tools (Healthcare) industry.
-
What has Stefan Eschbach invested in recently?
Stefan Eschbach's latest investment was on 08-Apr-2015 in Glycobond, a company within the Discovery Tools (Healthcare) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
